Streetbeat News

Revenues

IHRT

iHeartMedia has projected a mid-single digit decline in its Q3 consolidated revenue. The company also expects its consolidated adjusted EBITDA to be between $195M and $205M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:27 am

NEO

NeoGenomics has updated its FY23 revenue forecast to $565M-$575M, up from the previous estimate of $555M-$565M. However, the company also predicts a net loss of $107M-$100M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:27 am

CECO

CECO Environmental Corp. has increased its FY23 revenue guidance to $500M-$525M, up from the previous expectation of exceeding $485M. The company also updated its FY23 adjusted EBITDA forecast to be between $50M and $55M, a 25% increase at the mid-point year over year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:19 am

WOW

WideOpenWest (WOW) has projected its FY23 revenue to be between $691M and $696M, which is lower than the estimated $702.59M. The company also expects its Q3 revenue to range from $173M to $176M, compared to the estimated $175.51M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:11 am

GLBE

Global-e Online Ltd has updated its Q3 revenue forecast to $136M-$142M, which is lower than the estimated $142.57M. The company also revised its FY23 revenue projection to $570M-$596M, slightly higher than the previous range of $562M-$590M, but still below the estimated $583.28M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:08 am

MASS

908 Devices has projected its FY23 revenue to be between $49M and $52M, which is in line with the estimated $49.44M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:06 am

XERS

Xeris Biopharma has revised its FY23 revenue outlook to $145M - $165M, up from the previous range of $135M to $165M. The company also reduced its cash utilization range to $57M to $67M and improved its year-end cash range to $55M to $65M. Xeris expects to reach cash flow breakeven point in the fourth quarter.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:05 am

CRNC

Cerence Inc. has projected its Q4 revenue to be between $72M and $76M, which is in line with the estimated $72.06M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 11:01 am

PLTK

Playtika has revised its FY23 revenue forecast to the lower end of the previously provided range of $2.57B-$2.62B, which is slightly below the estimated $2.61B. The company also expects to be at the higher end of the Credit Adj. EBITDA range of $805M-$830M. Capital expenditures are now expected to be between $100M and $105M, down from $115M-$120M.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 10:39 am

BEAM

Beam Therapeutics anticipates that its cash, cash equivalents, and marketable securities of $1.1 billion will be sufficient to fund its operating expenses and capital expenditure requirements until at least 2025.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 10:36 am